Similarly, dysfunctional cDCs, termed “mregDC,” possess a unique immunoregulatory program upon uptake of tumor antigens and seem to preferentially engage with exhausted, antigen-experienced CD4 T cells (72). The gene discussed is CD4; the disease is neoplasm.